Mechanisms involved in microglial-interceded alzheimer’s disease and nanocarrier-based treatment approaches

Medicine and Dentistry

• Alzheimer's Disease 100%
• Nanocarrier 100%
• Oxidative Stress 16%
• Tau 16%
• Neuroinflammation 16%
• Cell Signaling Pathway 16%
• Tau Protein 16%
• Neurodegenerative Disorder 16%
• Combination Therapy 16%
• Amyloid Beta 16%
• Drug Delivery System 16%
• NLR Family Pyrin Domain containing 3 16%
• Glycogen Synthase Kinase 16%
• Microglia 16%
• Cognitive Defect 16%
• Neurotransmitter 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanocarrier 100%
• Alzheimer's Disease 100%
• Diseases 14%
• Nervous System Inflammation 14%
• Cognitive Defect 14%
• Drug Delivery System 14%
• Neurotransmitter 14%
• Combination Therapy 14%
• Amyloid Protein 14%
• Tau Protein 14%
• Targeted Drug Delivery 14%
• Glycogen Synthase Kinase 14%

Neuroscience

• Alzheimer's Disease 100%
• P38 Mitogen-Activated Protein Kinases 33%
• Oxidative Stress 16%
• Neurodegenerative Disorder 16%
• Neurotransmitter 16%
• Tau Protein 16%
• Targeted Drug Delivery 16%
• Microglia 16%
• Beta Amyloid 16%
• Cognitive Disorder 16%
• Etiology of Alzheimer's Disease 16%
• Synaptic Plasticity 16%